// App-Quantinova.ai

PB0078 : Lupus anticoagulant as predictor for thrombosis in critically ill COVID-19 patients: a retrospective cohort study

Researchers

Presenter

  • T. Noordermeer

Principal Investigators

  • R. Schutgens

  • C. Visser

  • M. de Maat

  • A. Jansen

  • M. Limper

  • M. Kruip

  • C. Maas

  • B. de Laat

  • R. Urbanus

Medical Centers

  • Center for Benign Haematology, Thrombosis and Haemostasis, Van Creveldkliniek, University Medical Center Utrecht, University Utrecht, Utrecht, the Netherlands, Utrecht, Utrecht, Netherlands

  • Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands, Utrecht, Utrecht, Netherlands

  • Transplantation, Erasmus MC, University Medical Center, Rotterdam, Netherlands

  • Department of Rheumatology/Clinical Immunology, University Medical Center Utrecht, Utrecht, The Netherlands., Utrecht, Netherlands

  • Department of Intensive Care Medicine, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands, Utrecht, Utrecht, Netherlands

  • Department of Hepatology, Erasmus MC, University Medical Center Rotterdam, the Netherlands, Rotterdam, Netherlands

  • Department of Adult Intensive Care, Erasmus Medical Center Rotterdam, Rotterdam, the Netherlands, Rotterdam, Zuid-Holland, Netherlands

  • UMC Utrecht, Utrecht, Netherlands

  • Department of Functional Coagulation, Synapse Research Institute, Maastricht, the Netherlands;, Maastricht, Limburg, Netherlands

Locations

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Autoimmune (AI)

  • Pulmonary/Respiratory Diseases

  • Infectious Diseases (ID)

  • Blood/haematological Diseases

Disease

  • Venous thrombosis

  • Coronavirus disease

  • Lupus

Biomarkers

  • Coagulation Factor III, Tissue Factor

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A